首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >CARDIAC FUNCTION AND STRUCTURE IN LONGITUDINAL ANALYSIS OF ECHOCARDIOGRAPHY IN PERITONEAL DIALYSIS PATIENTS
【24h】

CARDIAC FUNCTION AND STRUCTURE IN LONGITUDINAL ANALYSIS OF ECHOCARDIOGRAPHY IN PERITONEAL DIALYSIS PATIENTS

机译:腹膜透析患者超声心动图纵向分析中的心脏功能和结构

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Echocardiography is widely used for the evaluation of cardiac structures and function. The prognostic value of assessment of left cardiac atrium (LA) size in peritoneal dialysis (PD) patients is still unclear. The objective of the present study is to investigate prospectively a longitudinal monitoring of echocardiography parameters after start of PD. We also investigated a correlation study among plasma atrial natriuretic peptide (ANP) level, LA size, and cardiac function undergoing aggressive treatment.Methods: Correlation among plasma AN P, LA size, and cardiac function was prospectively analyzed by Doppler echocardiography in 32 PD patients in Juntendo University Hospital, Tokyo. Measurement of these parameters was performed at 0,6,12,18, and 24 months after start of PD. All patients were treated with an angiotensin type 1 receptor blocker to control blood pressure to less than 140/90 mmHg. Other antihypertensive drugs such as diuretics and/or calcium channel blockers were added if blood pressure rose to over 140/90 mmHg. Hemoglobin and hematocrit levels were targeted at 10.0 g/dL and 30.0% respectively with recom-binant human erythropoietin treatment. A diuretic was added or patients decreased their water intake if ANP was more than 43.0 pg/mL or LA diameter (LAD) more than 39 mm, and for other basic markers of volume status. Cardiac function was measured before and after drainage of PD fluid to evaluate the influence of cardiac function.Results: LAD at start of dialysis (36 +-4.6 mm) decreased significantly to 33 +- 3.3 mm (p< 0.05), 33 +- 3.2 mm (p < 0.05), and 33 +- 3.6 mm (p < 0.05) after 6, 12, and 24 months, respectively. Ejection fraction after 6 months was significantly increased compared with that at start of dialysis (p< 0.05). Left ventricular mass index (LVMI) after 6,12, and 24 months was significantly decreased compared with that at start of dialysis (p < 0.05). ANP was 56 +-39 pg/mL at start of dialysis and decreased significantly to 33 +19 pg/mL after 24 months (p < 0.05). ANP was significantly correlated with LAD (r=0.412, p < 0.01), transmitral A wave flow velocity (r = 0.429, p < 0.01), and LVMI (r =0.426, p < 0.01). Instillation of the dialysis fluid did not affect any parameters except inferior vena cava dimension. Conclusion: This study demonstrates a reduction in LA size and LVMI in PD patients followed over 24 months. Left ventricular structure, contraction, and compliance were well preserved in PD patients undergoing aggressive treatment based on measurements of plasma ANP and LAD.
机译:背景:超声心动图广泛用于评估心脏结构和功能。腹膜透析(PD)患者评估左心房(LA)大小的预后价值仍不清楚。本研究的目的是前瞻性研究PD开始后对超声心动图参数的纵向监测。方法:采用多普勒超声心动图技术对32例PD患者的血浆AN P,LA大小与心功能之间的相关性进行前瞻性分析。在东京顺天堂大学医院。这些参数的测量在PD开始后的0、6、12、18和24个月进行。所有患者均接受1型血管紧张素受体阻滞剂治疗,以将血压控制在140/90 mmHg以下。如果血压升至140/90 mmHg以上,则应添加其他降压药,例如利尿药和/或钙通道阻滞剂。重组人促红细胞生成素治疗将血红蛋白和血细胞比容水平分别定为10.0 g / dL和30.0%。如果ANP大于43.0 pg / mL或LA直径(LAD)大于39 mm,则添加利尿剂或患者减少饮水量,以及其他基本的体位指标。结果:透析开始时的LAD(36 + -4.6 mm)明显降低至33 +-3.3 mm(p <0.05),33 +- 6、12和24个月后分别为3.2毫米(p <0.05)和33±3.6毫米(p <0.05)。与透析开始时相比,6个月后的射血分数显着增加(p <0.05)。与透析开始时相比,左室质量指数(LVMI)在6,12和24个月后显着降低(p <0.05)。透析开始时的ANP为56 + -39 pg / mL,24个月后ANP显着降低至33 +19 pg / mL(p <0.05)。 ANP与LAD(r = 0.412,p <0.01),透射A波流速(r = 0.429,p <0.01)和LVMI(r = 0.426,p <0.01)显着相关。除了下腔静脉尺寸外,滴注透析液不影响任何参数。结论:这项研究表明,在24个月内,PD患者的LA大小和LVMI减小。根据血浆ANP和LAD的测量结果,接受积极治疗的PD患者的左心室结构,收缩和顺应性得到了很好的保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号